Advarra

We're heading to the Windy City for the 2024 Society of Research Administrators International Annual Meeting! If you'll be at SRAI this year, be sure to catch Advarra's Cheryl Byers, MHA, CIP, CHRC's and Daniel Eisenman PhD, CBSP's speaking sessions – details & times below. 👇 We're so excited to gather, network, and learn with our fellow institutional/site research colleagues. See you in Chicago from October 26-30! https://lnkd.in/eECK4k63

As Nick Spittal states in a recent Advarra press release, membership in the Gene Therapy Ready (GTR) site network "allows Velocity to start studies over a month faster and provides a meaningful credential and important validation that increases sponsors' confidence in our specialized capabilities to conduct complex clinical research safely." All Velocity sites are fully prepared to support cell and gene therapy (CGT) clinical trials. With 220+ investigators, a global laboratory network, and sites with longstanding specialty research experience, Velocity can deliver patients for everything from large vaccine trials to focused cancer and rare disease trials involving genetically engineered therapies. Read the full press release: https://lnkd.in/g2kKM3Gs #ClinicalTrials #GeneTherapy

We're proud and excited to share that Advarra has registered more Cell and Gene Therapy (CGT) ready sites than all other institutional biosafety committee (IBC) review providers combined to create the largest CGT site network in clinical research! 💪 We've now vetted more than 1,500 sites for our Gene Therapy Ready (GTR) site network through a robust evaluation process to confirm specialized expertise and infrastructure capabilities. CGT innovation is moving at lightning speed, with the number of CGT investigational new drug applications more than doubling since 2017. The potential for these therapies in treating rare diseases, changing, and saving lives is immense. Complex research barriers, costs, and hurdles shouldn't stand in the way of that. Our expansive GTR network helps... ⚡ provide critical safety oversight of CGT trials and enables sponsors and CROs to start trials faster. CROs and sponsors that select Advarra’s GTR sites activate 2x faster than traditional sites using a local IBC, and 6x faster than sites not part of Advarra’s GTR network. ⚡ sites and institutions meet biosafety requirements and benefit from hands-on, customized support to ensure proper training of all types of complex CGT trials. ⚡ enable broader patient access with a 1500+ site network across many regions, allowing a more diverse population of patients to receive care options. Together, we continue to reimagine the future of clinical research. Read more about the milestone here: https://lnkd.in/g2kKM3Gs #ClinicalResearch #ClinicalTrials #CellandGeneTherapy

Our SVP, Site-Sponsor Innovation, Christine Senn, PhD, is heading to the 2024 Innovation Network Gathering in a few short days! We're looking forward to having Christine there to co-host and meet with fellow clinical trial professionals as they work together to solve some of the toughest challenges on the road to more human-centric clinical trials, develop the solutions, and accelerate implementation. More information here: https://lnkd.in/g2sstcp4 Reach out to Christine if you'll be at the conference and want to connect! #ClinicalResearch #ClinicalTrials

Looking for your new role in clinical research technology and review services? Check out these open positions with our Review Services and Tech Products teams! Join us in reimagining the future of clinical trials. Advarra is making a significant impact in the world of research innovation, and we’d love to meet you. Learn more and apply at the links below: Coordinator II, Meeting Coordination – https://bit.ly/3MMYKht Sr. Coordinator, Client Experience – https://bit.ly/4e4r5Mo Associate Manager, Global Review Operations – https://bit.ly/4ebLX3O  Sr. Software Automation Test Engineer- C#.Net Framework – https://bit.ly/4fRELeU  Data Architect – https://bit.ly/3Tz1ZNv #ClinicalTrials #ClinicalResearch #HealthcareInnovation #TechJobs #TechSales #HumanResources #Hiring

To foster diversity and inclusion in the clinical research industry, building trust is absolutely critical. And making treatments effective and safe for all patients regardless of race, ethnicity, socioeconomic status, and other factors requires a multifaceted approach across the entire industry. In his latest piece for Forbes Technology Council, our CEO Gadi Saarony shares insights into why fear and mistrust of clinical trials still exists in many communities today, despite research being highly regulated, and how we can leverage technology to increase trust. Read it here: https://lnkd.in/epdza8kP #ClinicalResearch #ClinicalTrials #DEI

Decentralized clinical trials have gained significant traction in recent years by making research more accessible to patients. Today, most protocols reviewed by Advarra’s IRB include decentralized components, and our review services include robust mechanisms to ensure safety nets are in place for all models—both traditional and decentralized. The FDA’s final guidance on ‘Conducting Clinical Trials with Decentralized Elements’ brings the FDA guidance closer to HHS regulations with respect to engaged in research, and offers important guidance on IRB oversight to ensure consistent protection of patient safety across decentralized settings. This guidance reinforces the benefits of a central IRB to improve consistency of review across all settings and aligns with the use of a single IRB (sIRB), which is expected to be mandated for certain studies in mid-2025. https://lnkd.in/e-yyT5a5 #DCT #Decentralizedclinicaltrials

Electronic workflows have radically changed the way we do business. But in healthcare and clinical research, we've had a more fragmented experience in the adoption of technologies. Nowhere is this more painful than in clinical trials. Sites, sponsors, physicians, patients, and regulators may all use different software systems to manage documents, which means any mistakes in collecting and analyzing data could result in months of delays and potentially millions of dollars lost – not to mention delays in delivering new therapies to patients. But Advarra is proud to reimagine the future of clinical trials with Longboat, a centralized hub designed to guide and connect all stakeholders, enabling real-time collaboration and streamlining critical workflows. 💪 Here are five ways Longboat simplifies trial management, from streamlining regulatory submissions to ensuring audit-ready document storage. Learn more here: https://lnkd.in/g9kc6mFm #ClinicalTrials #ClinicalResearch #HealthcareInnovation

Please join us in welcoming Jeremy Allard to Advarra! 👏 Our newest Managing Director of GxP Services has over a decade of experience in clinical research and a background in science and healthcare law. Jeremy has expertise in integrating Quality into every stage of the clinical trial lifecycle. Most recently, he's led teams at a Top 50 Pharma organization, supporting uniquely complex clinical trials. Jeremy, we’re thrilled to have you on board! #NewHire #ClinicalResearch #ClinicalTrials

Much of the burden experienced in clinical research comes down to fragmented communication across systems and teams. Vinh La, Clinical Operations Lead involved in a multi-cohort, Global Phase II Oncology study, turned to Advarra Longboat to centralize critical communication and documents. Longboat helps streamline key workflows and improve collaboration between its 180,000 users every day. See how you can cut down on fragmented communication and improve compliance today by clicking the link in our comments below. ⬇️ #ClinicalResearch #ClinicalTrials